ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.
作者信息
Tomioka Atsushi, Uchiyama Kazuhisa
机构信息
Department of General and Gastroenterological Surgery, Osaka Medical College, Takatsuki, Osaka, Japan.
出版信息
Ann Surg Oncol. 2021 Jul;28(7):3798-3799. doi: 10.1245/s10434-020-09413-6. Epub 2020 Nov 24.
PMID:33236253
Abstract
摘要
相似文献
1
ASO Author Reflections: Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.
Ann Surg Oncol. 2021 Jul;28(7):3798-3799. doi: 10.1245/s10434-020-09413-6. Epub 2020 Nov 24.
2
ASO Author Reflections: Should we Stick our Neck Out for Pancreatic Neck Margins During Pancreaticoduodenectomy After Neoadjuvant Therapy?ASO作者反思：新辅助治疗后胰十二指肠切除术中，我们是否应该为胰腺颈部切缘冒险？
Ann Surg Oncol. 2022 Sep;29(9):6013-6014. doi: 10.1245/s10434-022-11843-3. Epub 2022 Apr 29.
3
Association Between Neoadjuvant Chemoradiotherapy and Intractable Serous Ascites After Pancreaticoduodenectomy for Pancreatic Cancer.新辅助放化疗与胰腺癌胰十二指肠切除术后难治性浆液性腹水的关系。
Ann Surg Oncol. 2021 Jul;28(7):3789-3797. doi: 10.1245/s10434-020-09401-w. Epub 2020 Nov 26.
4
ASO Author Reflections: Postoperative Chemotherapy After Neoadjuvant Therapy and Pancreatectomy for Pancreatic Cancer: Balancing Patient Physiology and Disease Biology.ASO作者反思：新辅助治疗和胰腺癌胰十二指肠切除术后的辅助化疗——平衡患者生理机能与疾病生物学特性
Ann Surg Oncol. 2021 Oct;28(11):6803-6804. doi: 10.1245/s10434-021-09896-x. Epub 2021 Mar 27.
5
ASO Author Reflections: Minimally Invasive Pancreaticoduodenectomy for Pancreatic Cancer: Are We Maximizing Delivery of Multimodality Therapy?ASO作者反思：胰腺癌的微创胰十二指肠切除术：我们是否在最大限度地提供多模式治疗？
Ann Surg Oncol. 2022 Nov;29(12):7804-7805. doi: 10.1245/s10434-022-12427-x. Epub 2022 Aug 13.
6
ASO Author Reflections: Surgical Strategies for Pancreatic Body Cancers with Portal Vein Involvement: Distal Pancreatectomy or Pancreaticoduodenectomy?ASO作者反思：门静脉受累的胰体癌的手术策略：远端胰腺切除术还是胰十二指肠切除术？
Ann Surg Oncol. 2024 Feb;31(2):1366-1367. doi: 10.1245/s10434-023-14663-1. Epub 2023 Nov 30.
7
ASO Author Reflections: Central Pancreatectomy Versus Distal Pancreatectomy and Pancreaticoduodenectomy for Benign or Low-Grade Malignant Neoplasms: A Propensity Score-Matched Study with Long-Term Functional Outcomes and Pancreas Volumetry.ASO作者反思：针对良性或低度恶性肿瘤的胰体尾切除术与远端胰腺切除术及胰十二指肠切除术的比较：一项倾向评分匹配研究及长期功能结局与胰腺容积测定
Ann Surg Oncol. 2020 Apr;27(4):1225-1226. doi: 10.1245/s10434-019-08133-w. Epub 2020 Jan 21.
8
ASO Author Reflections: The Clinical Dilemma of Para-Aortic Dissection in Pancreaticoduodenectomy for Ductal Adenocarcinoma.
Ann Surg Oncol. 2023 Mar;30(3):1483-1484. doi: 10.1245/s10434-022-12748-x. Epub 2022 Oct 27.
9
ASO Author Reflections: Superior Mesenteric Artery Dissection for Minimally Invasive Pancreaticoduodenectomy: A Technique That All Surgeons Should be Familiar With.ASO作者反思：用于微创胰十二指肠切除术的肠系膜上动脉解剖：一项所有外科医生都应熟悉的技术。
Ann Surg Oncol. 2023 Mar;30(3):1504-1505. doi: 10.1245/s10434-022-12820-6. Epub 2022 Nov 19.
10
ASO Author Reflections: Pancreatic Cancer Having Tumor Contact with an Aberrant Right Hepatic Artery Should be Regarded as Technically Resectable but Oncologically Borderline-Resectable.ASO作者反思：与异常右肝动脉有肿瘤接触的胰腺癌应被视为技术上可切除但肿瘤学上接近可切除。
Ann Surg Oncol. 2022 Aug;29(8):4989-4990. doi: 10.1245/s10434-022-11639-5. Epub 2022 Apr 21.
Zotero 插件